ProQR Therapeutics (PRQR) Non-Current Assets (2021 - 2025)

ProQR Therapeutics' Non-Current Assets history spans 4 years, with the latest figure at $15.1 million for Q4 2024.

  • For Q4 2024, Non-Current Assets fell 17.05% year-over-year to $15.1 million; the TTM value through Dec 2024 reached $15.1 million, down 17.05%, while the annual FY2024 figure was $15.3 million, 16.43% down from the prior year.
  • Non-Current Assets for Q4 2024 was $15.1 million at ProQR Therapeutics, down from $18.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $20.7 million in Q4 2021 and bottomed at $15.1 million in Q4 2024.
  • The 4-year median for Non-Current Assets is $17.7 million (2023), against an average of $17.8 million.
  • The largest annual shift saw Non-Current Assets increased 5.68% in 2023 before it decreased 17.05% in 2024.
  • A 4-year view of Non-Current Assets shows it stood at $20.7 million in 2021, then dropped by 16.9% to $17.2 million in 2022, then grew by 5.68% to $18.2 million in 2023, then decreased by 17.05% to $15.1 million in 2024.
  • Per Business Quant, the three most recent readings for PRQR's Non-Current Assets are $15.1 million (Q4 2024), $18.2 million (Q4 2023), and $17.2 million (Q4 2022).